View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
Carole Braudeau
  • Carole Braudeau

Credit Morning 05/13/2025

Cellnex issues € 750m of new 2032 notes|Grifols : Q1 2025 earnings above expectations, FY guidance maintained despite weaker US dollar|90-day truce in the trade war between the United States and China|

Carole Braudeau
  • Carole Braudeau

Morning Crédit 13/05/2025

Cellnex émet 750 m EUR de nouvelles obligations 2032|Grifols : résultats supérieurs aux attentes au T1 2025, guidance annuelle confirmée malgré la dépréciation du dollar US|Trêve de 90 jours dans la guerre commerciale entre les Etats-Unis et la Chine|

Cedric Rossi ... (+3)
  • Cedric Rossi
  • Clement Genelot
  • Loic Morvan

On the shelves now: Consumer Weekly #69

In this Consumer Weekly newsletter, we provide a brief overview of the key factors affecting our Consumer coverage, from Luxury & Consumer goods to Retail & E-commerce and Food & Ingredients. This week, we look at how increased consumer anxiety about tariffs leads to diverging trends be

Lvmh Moet Hennessy Louis Vuitton SE: 1 director

A director at Lvmh Moet Hennessy Louis Vuitton SE bought 71,864 shares at 487.019EUR and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the...

Carole Braudeau
  • Carole Braudeau

Credit Morning 05/08/2025

Branicks Q1 25 results: Further increase in vacancy; fundamentally not improving|Teva: Q1 2025 results up slightly. Strong momentum in innovative medicines and the new efficiency programme lend credibility to the 2027 guidance.|TPG steps away from Techem acquisition; documentation subject to special call|Banco BPM reports solid Q1 performance|

Carole Braudeau
  • Carole Braudeau

Morning Crédit 08/05/2025

Branicks Q1 25 results: Further increase in vacancy; fundamentally not improving|Teva : résultats au T1 2025 en légère hausse. La bonne dynamique des médicaments innovants et le nouveau programme d’efficience crédibilisent la guidance 2027.|TPG steps away from Techem acquisition; documentation subject to special call|BPM publie un trimestre record et au-dessus des attentes|

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch